Carin M Van Gelder
Overview
Explore the profile of Carin M Van Gelder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Selker H, Udelson J, Massaro J, Ruthazer R, DAgostino R, Griffith J, et al.
Am J Cardiol
. 2014 May;
113(10):1599-605.
PMID: 24792735
The Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care Trial of very early intravenous glucose-insulin-potassium (GIK) for acute coronary syndromes (ACS) in out-of-hospital emergency medical service...
3.
Van Gelder C, Hoogeveen-Westerveld M, Kroos M, Plug I, van der Ploeg A, Reuser A
J Inherit Metab Dis
. 2014 Apr;
38(2):305-14.
PMID: 24715333
Background: Enzyme-replacement therapy (ERT) in Pompe disease--an inherited metabolic disorder caused by acid α-glucosidase deficiency and characterized in infants by generalized muscle weakness and cardiomyopathy--can be complicated by immune responses....
4.
Wens S, Van Gelder C, Kruijshaar M, de Vries J, van der Beek N, Reuser A, et al.
Orphanet J Rare Dis
. 2013 Nov;
8:182.
PMID: 24245577
Background: Pompe disease has a broad clinical spectrum, in which the phenotype is partially explained by the genotype. The aim of this study was to describe phenotypical variation among siblings...
5.
Rigter T, Weinreich S, van El C, de Vries J, Van Gelder C, Gungor D, et al.
Mol Genet Metab
. 2012 Oct;
107(3):448-55.
PMID: 23040796
Since the introduction of enzyme replacement therapy for Pompe disease, awareness and early diagnosis have gained importance. Because the therapy is most effective when started early and methods for dried...
6.
Van Gelder C, Vollebregt A, Plug I, van der Ploeg A, Reuser A
Expert Opin Pharmacother
. 2012 Sep;
13(16):2281-99.
PMID: 23009070
Introduction: Lysosomal storage disorders (LSDs) are clinically heterogeneous disorders that result primarily from lysosomal accumulation of macromolecules in various tissues. LSDs are always progressive, and often lead to severe symptoms...
7.
Sluiter W, van den Bosch J, Goudriaan D, Van Gelder C, de Vries J, Huijmans J, et al.
Clin Chem
. 2012 May;
58(7):1139-47.
PMID: 22623745
Background: Urinary excretion of the tetrasaccharide 6-α-D-glucopyranosyl-maltotriose (Glc₄) is increased in various clinical conditions associated with increased turnover or storage of glycogen, making Glc₄ a potential biomarker for glycogen storage...
8.
Selker H, Beshansky J, Sheehan P, Massaro J, Griffith J, DAgostino R, et al.
JAMA
. 2012 Mar;
307(18):1925-33.
PMID: 22452807
Context: Laboratory studies suggest that in the setting of cardiac ischemia, immediate intravenous glucose-insulin-potassium (GIK) reduces ischemia-related arrhythmias and myocardial injury. Clinical trials have not consistently shown these benefits, possibly...
9.
Landman A, Lee C, Sasson C, Van Gelder C, Curry L
PLoS One
. 2012 Mar;
7(3):e32692.
PMID: 22403698
Background: As the United States embraces electronic health records (EHRs), improved emergency medical services (EMS) information systems are also a priority; however, little is known about the experiences of EMS...
10.
Landman A, Phipps M, Jawin K, Bolton L, Van Gelder C, Kamin R, et al.
Conn Med
. 2011 Jun;
75(5):261-8.
PMID: 21678837
Objectives: Assess the association of helmet use with motorcycle crash mortality and identify characteristics of riders who do not wear helmets in Connecticut crashes. Methods: Police crash data for Connecticut...